Kindai University · Faculty of Medicine · 助教

Research keywordsprostate cancer・bladder cancer・androgen deprivation therapy・androgen receptor signaling・abiraterone・brachytherapy・urogenital oncology

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Sequential therapy with darolutamide in patients with non‐metastatic castration‐resistant prostate cancer resistant to enzalutamide or apalutamide
• Iodine-125 low-dose rate prostate brachytherapy.
• Comparison of genetic mutations in bladder cancers that arose following radiotherapy for prostate cancer with those in primary bladder cancers.
• Comparison of Oncological Outcomes of Conventional Androgen Deprivation Therapy (ADT) and ADT Plus Androgen Receptor Signaling Inhibitor in Older Patients With Metastatic Castration-Sensitive Prostate Cancer.

• Official profile